SILENCE THER. (SLN)

 

SLN Share PerformanceMore

52 week high254.75 23/10/17
52 week low93.25 30/05/17
52 week change 57.65 (60.26%)
4 week volume132,229 01/05/18
price153.25
price date1527235474
close152.25

Latest NewsMore

Results of AGM

RNS Number: 8210L Silence Therapeutics PLC 24 April 2018 Results of AGM London, 24 th April 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that at its Annual General Meeting held on M...

Additional Listing

RNS Number: 5183L Silence Therapeutics PLC 19 April 2018 Additional listing 19 April 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has issued and allotted 48,309 new ordinary shares...

Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLC

Peel Hunt today reaffirms its buy investment rating on Silence Therapeutics PLC (LON:SLN) and set its price target at 277...

Silence Therapeutics brings patent infringement proceedings in Portugal

Silence Therapeutics said it had brought patent infringement proceedings in Portugal against Alnylam Pharmaceuticals's P...

Litigation Update (Portugal and US)

RNS Number: 5353J Silence Therapeutics PLC 03 April 2018 Litigation Update (Portugal and US) London, 3 rd April 2018 Silence Therapeutics plc, AIM:SLN ("the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that, through Silence Therapeutics Gmb...

Silence to Present at Scientific Conferences

RNS Number: 8236I Silence Therapeutics PLC 26 March 2018 Silence Therapeutics to Present at Upcoming Scientific Conferences in March and April 2018 London, 26 th March 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with...

Notice of AGM

RNS Number: 9044G Silence Therapeutics PLC 07 March 2018 Silence Therapeutics Notice of Annual General Meeting and publication of Annual Report London, 7 th March 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with u...

Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLC

Peel Hunt today reaffirms its buy investment rating on Silence Therapeutics PLC (LON:SLN) and raised its price target to ...

Fundamental DataMore

EPS-12.1
Dividend yield0 %

Latest discussion posts More

  • Re: Slow decline.

    Hi, Totally agree and I am not sure why apart from just general lack of interest. The attached might help cheer you up a ...
    27-Apr-2017
    tallyfox
  • Slow decline.

    Feels like death by a thousand cuts at the moment. What's it going to take to reverse this decline?
    27-Apr-2017
    rikid

Users' HoldingsMore

Users who hold SILENCE THER. also hold..

Codes & Symbols

ISINGB00B9GTXM62
SymbolsSLN, LSE:SLN, SLN.L, SLN:LN, LON:SLN, XLON:SLN